Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Kaohsiung J Med Sci ; 28(4): 236-40, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22453074

ABSTRACT

Good's syndrome, also known as thymoma with combined immunodeficiency, is rare. The immunodeficiency may precede, arise concurrently with or follow the diagnosis of thymoma. In addition to myasthenia gravis and Good's syndrome, paraneoplastic syndromes associated with thymoma can also be manifested with hematological disorders, such as pure red cell aplasia, aplastic anemia, agranulocytosis, hemolytic anemia, pernicious anemia, and paroxysmal nocturnal hemoglobinuria. Myelodysplastic syndrome is a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more lineages, ineffective hematopoiesis, and potential precursors of acute leukemia. One proposed pathogenesis of myelodysplasia is autoantibodies that directly reject against hematopoietic cells, but this situation is rare in thymoma. Herein, we report a thymoma patient with unique paraneoplastic syndromes who developed myelodysplasia prior to Good's syndrome. Early and accurate diagnosis of myelodysplastic syndrome is important for disease management, especially in patients whose myelodysplastic syndrome is possibly derived from autoimmunity. For thymoma patients with recurrent infections, comprehensive immunologic studies to exclude the possibility of Good's syndrome and prophylactic intravenous immunoglobulin infusion in suitable candidates are warranted.


Subject(s)
Myelodysplastic Syndromes/diagnosis , Thymoma/diagnosis , Female , Humans , Middle Aged , Myelodysplastic Syndromes/etiology , Paraneoplastic Syndromes/diagnosis , Paraneoplastic Syndromes/etiology , Thymoma/complications
2.
Environ Mol Mutagen ; 52(7): 529-37, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21538558

ABSTRACT

This study investigates the effects of fenthion and terbufos, two organophosphorous pesticides, on DNA damage, tumor-related gene expression, and apoptosis in HepG2 cells. We found that exposure to concentrations ranging from 50 to 200 µM of fenthion and terbufos for 2 hr caused significant death in HepG2 cells. Both compounds induced DNA damage in a concentration-dependent manner as measured using the alkaline comet assay. Tumor-related genes (jun, myc, and fos) and apoptosis-related genes (socs3, tnfaip3, ppp1r15a, and nr4a1) were up-regulated by both compounds. Finally, both compounds induced apoptosis. The results demonstrate that both terbufos and fenthion induce DNA damage and should be considered potentially hazardous to humans.


Subject(s)
Apoptosis/drug effects , DNA Damage/drug effects , Fenthion/toxicity , Gene Expression Regulation, Neoplastic/drug effects , Organothiophosphorus Compounds/toxicity , Pesticides/toxicity , Cell Survival/drug effects , Comet Assay , Hep G2 Cells , Humans
SELECTION OF CITATIONS
SEARCH DETAIL